Grant: Idea to Innovation
University of Toronto
$125,000.00
Scale-up of a novel hyaluronan-based delivery system
EF 2020-21
Résumé
A hydrogel platform was engineered to provide sustained release of biomolecules. The product addresses an unmet need in the post-operative pain market and will provide extended pain-relief to the user. This proposal focuses on optimizing the formulation for sustained release based on a series of design criteria, scale-up manufacturing, sterility and stability.
We propose to build on a successful phase I I2I where we formed and financed AmacaThera with $4.7million in seed capital. In this phase IIb I2I proposal, we aim to advance the manufacturing and scale-up of a product designed for post-operative pain to ensure that we can manufacture at scale a uniform product, with controlled release attributes that is both sterile and stable on the shelf.
This proposal is a strong academic-industry partnership between The Shoichet Lab and AmacaThera, taking advantage of research excellence from the Shoichet lab and business acumen from AmacaThera.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
548822-2020
Name nom
Shoichet, Molly
Department département
Chemical Engineering and Applied Chemistry
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
125000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Scale-up of a novel hyaluronan-based delivery system
Keyword
NSERC
Application summary
A hydrogel platform was engineered to provide sustained release of biomolecules. The product addresses an unmet need in the post-operative pain market and will provide extended pain-relief to the user. This proposal focuses on optimizing the formulation for sustained release based on a series of design criteria, scale-up manufacturing, sterility and stability.
We propose to build on a successful phase I I2I where we formed and financed AmacaThera with $4.7million in seed capital. In this phase IIb I2I proposal, we aim to advance the manufacturing and scale-up of a product designed for post-operative pain to ensure that we can manufacture at scale a uniform product, with controlled release attributes that is both sterile and stable on the shelf.
This proposal is a strong academic-industry partnership between The Shoichet Lab and AmacaThera, taking advantage of research excellence from the Shoichet lab and business acumen from AmacaThera.